NCT04438668 - Evaluation of the Safety and Performance of Centaflow | Biotech Hunter

Enrollment

1,704

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Fetal Growth Restriction

Interventions

DEVICE

Centaflow and Standard Care

The intervention is screening methods

DIAGNOSTIC_TEST

Standard Care

The intervention is screening methods

Trial Locations (2)

RECRUITING

Juliane Marie Centeret, Rigshospitalet, Copenhagen

RECRUITING

Obstetrical Department, Regional Hospital Viborg, Viborg